Inhibition of Constitutive Nitric Oxide Production Increases the Severity of Lipopolysaccharide-Induced Sickness Behaviour: A Role for TNF-α
- 1 January 2002
- journal article
- research article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 10 (6) , 367-378
- https://doi.org/10.1159/000071478
Abstract
Administration of bacterial lipopolysaccharide (LPS) to rodents induces hypophagia, body weight loss and hypolocomotion, a constellation of symptoms collectively referred to as ‘sickness behaviour’. We examined the role of the gaseous transmitter nitric oxide (NO) in mediating LPS-induced sickness behaviour in rats. Treatment with the non-selective NO synthase (NOS) inhibitor NG-nitro-L-arginine (L-NA) (20 mg/kg; i.p.) increased the severity of LPS-induced sickness behaviour in rats, suggesting that endogenous NO does not act as a mediator of LPS-induced sickness behaviour, but may rather have a protective role, acting in an inhibitory feedback manner to limit LPS-induced sickness. To evaluate the role of the different NOS isoforms in this response, we examined the effect of the neuronal NOS inhibitor, 7-nitroindazole (7-NI; 25 and 50 mg/kg; i.p.), and the inducible NOS inhibitor, aminoguanidine (AGN; 50 and 100 mg/kg; i.p.). Neither 7-NI nor AGN significantly altered LPS-induced sickness behaviour. Therefore, it is likely that the endothelial isoform of NOS mediates the effect of L-NA on LPS-induced sickness behaviour. As pro-inflammatory cytokines are mediators of LPS-induced sickness behaviour, we examined the effect of L-NA (20 mg/kg; i.p.) on LPS-induced interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α production. L-NA increased LPS-induced TNF-α without significantly altering IL-1β or IL-6 production. Moreover, pre-treatment with the TNF-α inhibitor pentoxyfilline (25 mg/kg; i.p.) largely reversed the augmenting effect of L-NA on LPS-induced sickness behaviour, suggesting that the ability of L-NA to increase TNF-α production underpinned its ability to increase the severity of sickness. In conclusion, L-NA increases the severity of LPS-induced sickness behaviour, most likely by blocking the tonic inhibitory action of constitutively produced NO on TNF-α production.Keywords
This publication has 20 references indexed in Scilit:
- Interleukin-1β stimulates cyclic GMP efflux in brain astrocytesFEBS Letters, 2001
- Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1β and TNF-α secretion following an in vivo lipopolysaccharide challengeLife Sciences, 2000
- Endotoxin Stimulates Nitric Oxide Production in the Paraventricular Nucleus of the Hypothalamus through Nitric Oxide Synthase I: Correlation with Hypothalamic-Pituitary-Adrenal Axis ActivationEndocrinology, 1999
- Cytokines Inhibit Sexual Behavior in Female Rats: II. Prostaglandins Mediate the Suppressive Effects of Interleukin-1βBrain, Behavior, and Immunity, 1999
- Coincidental Changes in Behavior and Plasma Cortisol in Unrestrained Pigs after Intracerebroventricular Injection of Tumor Necrosis Factor-Endocrinology, 1997
- Effects of licorice derivatives on vascular smooth muscle functionLife Sciences, 1996
- Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in micePsychoneuroendocrinology, 1994
- The nitric oxide-cyclic GMP signalling pathway in rat brainNeuropharmacology, 1993
- Role of Nitric Oxide Pathway in the Protection Against Lethal Endotoxemia Afforded by Low Doses of LipopolysaccharideBiochemical and Biophysical Research Communications, 1993
- Behavioural effects of peripherally injected interleukin-1: role of prostaglandinsBrain Research, 1991